MPLX (NYSE:MPLX) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.81 by 2.47 percent. This is a 25.76 percent increase over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $2.94 billion which beat the analyst consensus estimate of $2.59 billion by 13.51 percent. This is a 22.76 percent increase over sales of $2.40 billion the same period last year.
MPLX Q2 EPS $0.83 Beats $0.81 Estimate, Sales $2.94B Beat $2.59B Estimate
MPLX (NYSE:MPLX) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.81 by 2.47 percent. This is a 25.76 percent increase over earnings of $0.66 per share from the same period
Related Posts
VYNE Therapeutics Q2 EPS $(0.35), Inline
VYNE Therapeutics (NASDAQ:VYNE) reported quarterly losses of $(0.35) per share which met the analyst consensus estimate. This is a 57.32 percent increase over losses of $(0.82) per share from the same period last year.
Mustang Bio Q3 EPS $(0.19) Up From $(0.23) YoY
Mustang Bio (NASDAQ:MBIO) reported quarterly losses of $(0.19) per share. This is a 17.39 percent increase over losses of $(0.23) per share from the same period last year.